Gene · 563
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Using plasma proteomics to investigate viral infections of the central nervous system including patients with HIV-associated neurocognitive disorders. | J Neurovirol | 2022 | 35639337 | PubTator, text mining | PubMed |
| Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer. | Front Endocrinol (Lausanne) | 2022 | 35634509 | PubTator, text mining | PubMed |
| Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma. | Cancer Sci | 2022 | 35633182 | PubTator, text mining | PubMed |
| Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer-When Does Cachexia Start? | Cells | 2022 | 35626644 | PubTator, text mining | PubMed |
| The significance of the fusion partner gene genomic neighborhood analysis in translocation-defined tumors. | Mol Genet Genomic Med | 2022 | 35621010 | PubTator, text mining | PubMed |
| Integration of Urine Proteomic and Metabolomic Profiling Reveals Novel Insights Into Neuroinflammation in Autism Spectrum Disorder. | Front Psychiatry | 2022 | 35615451 | PubTator, text mining | PubMed |
| Metabonomic analysis of cerebrospinal fluid in epilepsy. | Ann Transl Med | 2022 | 35571432 | PubTator, text mining | PubMed |
| Smart nanomaterials for cancer diagnosis and treatment. | Nano Converg | 2022 | 35569081 | PubTator, text mining | PubMed |
| Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line. | Clin Proteomics | 2022 | 35568821 | PubTator, text mining | PubMed |
| Distinct AMPK-Mediated FAS/HSL Pathway Is Implicated in the Alleviating Effect of Nuciferine on Obesity and Hepatic Steatosis in HFD-Fed Mice. | Nutrients | 2022 | 35565866 | PubTator, text mining | PubMed |
| Proteomics in Multiple Sclerosis: The Perspective of the Clinician. | Int J Mol Sci | 2022 | 35563559 | PubTator, text mining | PubMed |
| Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia. | Int J Mol Sci | 2022 | 35563307 | PubTator, text mining | PubMed |
| FastCAT Accelerates Absolute Quantification of Proteins Using Multiple Short Nonpurified Chimeric Standards. | J Proteome Res | 2022 | 35561006 | PubTator, text mining | PubMed |
| Elevated Circulatory Proline to Glutamine Ratio (PQR) in Endometriosis and Its Potential as a Diagnostic Biomarker. | ACS Omega | 2022 | 35557708 | PubTator, text mining | PubMed |
| Proteomic analysis of autoimmune retinopathy implicates NrCAM as a potential biomarker. | Ophthalmol Sci | 2022 | 35529077 | PubTator, text mining | PubMed |
| MicroRNA Profile of MA-104 Cell Line Associated With the Pathogenesis of Bovine Rotavirus Strain Circulated in Chinese Calves. | Front Microbiol | 2022 | 35516441 | PubTator, text mining | PubMed |
| 'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'. | Front Mol Biosci | 2022 | 35495618 | PubTator, text mining | PubMed |
| Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer. | Clin Proteomics | 2022 | 35477343 | PubTator, text mining | PubMed |
| Nutritional and Exercise Interventions in Cancer-Related Cachexia: An Extensive Narrative Review. | Int J Environ Res Public Health | 2022 | 35457471 | PubTator, text mining | PubMed |
| Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study. | Cancers (Basel) | 2022 | 35454907 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/563/papers?page=19